| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −7.1× | −1.7× | |
| Price / Book | −101.3× | 2.0× | |
| Price / Sales | 2.8× | 4.0× | |
| Price / Free cash flow | −10.5× | −1.6× | |
| EV / EBITDA | −13.8× | −1.1× | |
| Earnings yield | −14.1% | −14.6% | |
| Free cash flow yield | −9.5% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,247.98 | −0.72% | $1.17T | 57.3× | 77.8% | +16.7% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $253.87 | −0.66% | $611.8B | 23.0× | 32.9% | +33.7% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $283.31 | −0.74% | $500.64B | 119.3× | −129.2% | +26.2% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $406.07 | +1.16% | $364.49B | 29.9× | 12.8% | +11.2% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.14 | −1.24% | $355.62B | 19.7× | 34.7% | +73.5% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.17 | −0.30% | $277.8B | 19.8× | 30.5% | +15.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $164.09 | −0.80% | $254.49B | 25.0× | 21.1% | −2.2% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $680.69 | −1.35% | $251.68B | 37.9× | 12.6% | +30.7% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $425.61 | −1.59% | $230.1B | 30.3× | 89.1% | +45.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $153.59 | −1.66% | $190.44B | 22.8× | 37.5% | +32.0% |
